title: Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion.
abstract: The plasminogen activator/plasmin system is one of the main protease systems involved in tumor cell invasion and metastasis. Our previous study has shown that plasmin degrades E-cadherin and promotes cell dissemination by downregulation of E-cadherin-mediated cell-cell adhesion in oral squamous cell carcinoma (SCC) cells. To examine the effect of downregulation of the plasminogen activator/plasmin system by alpha2-antiplasmin (alpha2-AP) on cell-cell adhesion mediated by E-cadherin in oral SCC cells, the oral SCC cell line SCCKN was stably transfected with alpha2-AP cDNA. Induction of alpha2-AP expression led to the inhibition of the proteolysis of E-cadherin by plasminogen activator/plasmin in SCC cells, resulting in the enhancement of the cell aggregation and the suppression of the cell motility. Moreover, alpha2-AP also reduced the ability of SCC cells to invade type I collagen gel, and suppressed tumorigenicity in vivo. These results suggested that downregulation of the plasminogen activator/ plasmin system by alpha2-AP might be a potent therapeutic approach to prevent the progression of oral SCC.
authors.affiliation: Department of Molecular Oral Medicine and Maxillofacial Surgery, Division of Frontier Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8553, Japan. hayashiy@hiroshima-u.ac.jp
authors.forename: Yasutaka
authors.initials: Y
authors.lastname: Hayashido
authors.forename: Tomoaki
authors.initials: T
authors.lastname: Hamana
authors.forename: Yasutaka
authors.initials: Y
authors.lastname: Ishida
authors.forename: Tomoaki
authors.initials: T
authors.lastname: Shintani
authors.forename: Koh-Ichi
authors.initials: K
authors.lastname: Koizumi
authors.forename: Tetsuji
authors.initials: T
authors.lastname: Okamoto
mesh_terms: D000818:Animals; D015820:Cadherins / Q000378:metabolism*; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000473:pathology*; D002448:Cell Adhesion; D003094:Collagen / Q000378:metabolism; D018450:Disease Progression; D005341:Fibrinolysin / Q000378:metabolism*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009062:Mouth Neoplasms / Q000378:metabolism*; D010960:Plasminogen Activators / Q000378:metabolism*; D015854:Up-Regulation; D000979:alpha-2-Antiplasmin / Q000378:metabolism*
chemical_list: D015820:Cadherins; D000979:alpha-2-Antiplasmin; D003094:Collagen; D010960:Plasminogen Activators; D005341:Fibrinolysin